drugset / Trial / NCT03260205

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT03260205

Phase 3 Completed 199 enrolled Shire
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if an investigational treatment is effective in improving the total score on the ADHD-RS-IV Preschool Version in children 4-5 years old diagnosed with ADHD.

Timeline

Start
2017-09-06
Primary completion
2018-10-23
Completion
2018-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Lisdexamfetamine Dimesylate Small molecule 5 mg Oral
Subject Lisdexamfetamine Dimesylate Small molecule 10 mg Oral
Subject Lisdexamfetamine Dimesylate Small molecule 20 mg Oral
Subject Lisdexamfetamine Dimesylate Small molecule 30 mg Oral